SANTA CLARA, Calif. & BEIJING–Affymetrix Inc., (Nasdaq:AFFX) and CapitalBio Corporation, a leading life science company based in Beijing, P.R. China, announced that CapitalBio has become a certified Affymetrix Service Provider and will begin offering genotyping services using the Affymetrix GeneChip(R) Human Mapping 500K Array Set. The 500K Array enables researchers to search across the entire […]
SANTA CLARA, Calif. & CARLSBAD, Calif.–Affymetrix Inc. (Nasdaq:AFFX) and Invitrogen Corporation (Nasdaq:IVGN) announced today that Invitrogen has obtained a non-exclusive, worldwide license to a number of Affymetrix patents that will allow Invitrogen to manufacture and sell spotted nucleic acid microarrays in the research field. Financial details of the license were not disclosed.
Little Chalfont, UK: Stockholm, Sweden- GE Healthcare Life Sciences has agreed to acquire surface plasmon resonance company Biacore AB in an offer valued at SEK2,860 million ($390 million), net of Biacore cash and equivalents. GE Healthcare will pay SEK330 ($44.70) per share, a 17% premium over the stock’s closing price on June 19, and a […]
CARLSBAD, Calif. & HAYWARD, Calif. & CAMBRIDGE, United Kingdom–Invitrogen Corporation (Nasdaq:IVGN), a provider of essential life science technologies for disease research and drug discovery, and Solexa, Inc. (Nasdaq:SLXA), a provider of next-generation genetic analysis systems, announced a collaboration through which Invitrogen will supply many of the reagents for Solexa’s sequencing, gene expression, and small RNA […]
DANVERS, Mass.—Cell Signaling Technology, Inc. (CST), announced that it has entered into a new partnership agreement with Bio-Rad Laboratories, Inc. (AMEX: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics. Under the new agreement, CST will develop antibodies for kinase activation and protein phosphorylation assays that will be […]
PALO ALTO, Calif. & PARIS–Agilent Technologies Inc. (NYSE:A) and ExonHit Therapeutics (Euronext:ALEHT) announced that they have entered into a marketing alliance in which Agilent will market and sell nine different ExonHit human and mouse SpliceArrays as commercial products. These SpliceArrays include GPCR, Ion Channel, nuclear receptors and apoptosis pathways. SpliceArrays are a new generation of […]
Boston, MA –PerkinElmer has acquired the assets of Spectral Genomics for an undisclosed sum. Spectral Genomics provides microarrays and software for the identification of chromosomal abnormalities related to the study of cancer and pre-and post-natal genetic disorders. “Spectral Genomics’ innovative technologies are highly complementary to our current molecular medicine and genetic screening offerings,” said Robert […]
BRANFORD, Conn.,– 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation (Nasdaq: CRGN), and Roche Diagnostics today announced the launch of an updated version of the Genome Sequencer 20(TM) System. Version 1.02 of the Genome Sequencer 20 System comes with a bundle of improvements. The most important new features are: * a single read […]
SAN DIEGO–Illumina, Inc. (NASDAQ:ILMN) announced that it has introduced the Illumina AutoLoader to stage up to 40 high-density Sentrix(R) BeadChips for scanning on a BeadStation – sufficient for 15 hours of unattended, automated operation. Combined with a new software release for BeadStation that increases scan speed, system operators can now achieve scanning throughput 400% greater […]
SANTA CLARA, Calif.–Affymetrix Inc. (Nasdaq:AFFX) announced that Abbott Molecular, a division of Abbott, has obtained a non-exclusive, worldwide license to a number of Affymetrix patents that will allow it to manufacture and sell comparative genomic hybridization (CGH) microarrays, related readers and software in the research and diagnostics field. Details of the license were not disclosed.
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
